Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome

Study information

Reviewed Marked as Reviewed by Lwaldron on 2022/07/1

study design

case-control

Citation

PMID PubMed identifier for scientific articles.

22315951

DOI Digital object identifier for electronic documents.

10.1111/j.1365-2036.2012.05007.x

URI

Authors

Chassard C, Dapoigny M, Scott KP, Crouzet L, Del'homme C, Marquet P, Martin JC, Pickering G, Ardid D, Eschalier A, Dubray C, Flint HJ, Bernalier-Donadille A

Journal

Alimentary pharmacology & therapeutics

Year

2012

BACKGROUND: The role of the gut microbiota in patho-physiology of irritable bowel syndrome (IBS) is suggested by several studies. However, standard cultural and molecular methods used to date have not revealed specific and consistent IBS-related groups of microbes. AIM: To explore the constipated-IBS (C-IBS) gut microbiota using a function-based approach. METHODS: The faecal microbiota from 14 C-IBS women and 12 sex-match healthy subjects were examined through a combined strictly anaerobic cultural evaluation of functional groups of microbes and fluorescent in situ hybridisation (16S rDNA gene targeting probes) to quantify main groups of bacteria. Starch fermentation by C-IBS and healthy faecal samples was evaluated in vitro. RESULTS: In C-IBS, the numbers of lactate-producing and lactate-utilising bacteria and the number of H(2) -consuming populations, methanogens and reductive acetogens, were at least 10-fold lower (P < 0.05) compared with control subjects. Concomitantly, the number of lactate- and H(2) -utilising sulphate-reducing population was 10 to 100 fold increased in C-IBS compared with healthy subjects. The butyrate-producing Roseburia - E. rectale group was in lower number (0.01 < P < 0.05) in C-IBS than in control. C-IBS faecal microbiota produced more sulphides and H(2) and less butyrate from starch fermentation than healthy ones. CONCLUSIONS: A major functional dysbiosis was observed in constipated-irritable bowel syndrome gut microbiota, reflecting altered intestinal fermentation. Sulphate-reducing population increased in the gut of C-IBS and were accompanied by alterations in other microbial groups. This could be responsible for changes in the metabolic output and enhancement in toxic sulphide production which could in turn influence gut physiology and contribute to IBS pathogenesis.

Experiment 1

Edit History Delete

Mark reviewed

Your review change was submittedDuplicate this Experiment Add a new Signature

Needs review

Curated date: 2022/01/28

Curator: Kwekuamoo

Revision editor(s): WikiWorks, LGeistlinger, Lwaldron, Rimsha, Kwekuamoo, Peace Sandy

Subjects

Location of subjects: France

Host species Species from which microbiome was sampled. Contact us to have more species added.: Homo sapiens

Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology: Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces

Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology

Group 0 name Corresponds to the control (unexposed) group for case-control studies: Healthy Control

Group 1 name Corresponds to the case (exposed) group for case-control studies: constipated-IBS

Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group: The 14 women IBS patients (age range: 36–59, mean age: 48) included in this study fulfilled the Rome II criteria for IBS. They were classified as IBS with constipation (C-IBS) by a questionnaire following the Rome II subgrouping criteria which have been recognized as valid also in the Rome III criteria.

Group 0 sample size Number of subjects in the control (unexposed) group: 12

Group 1 sample size Number of subjects in the case (exposed) group: 14

Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any): Exclusion criteria included organic intestinal disease, other systemic disease, previous abdominal surgery, lactation, pregnancy, dementia or inadequate cooperative capability and antibiotic therapy during the previous 2 months.

Lab analysis

Sequencing type: 16S

16S variable region One or more hypervariable region(s) of the bacterial 16S gene: Not specified

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).: relative abundances

Statistical test: T-Test

Significance threshold p-value or FDR threshold used for differential abundance testing (if any): 0.05

MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?: No

Matched on Factors on which subjects have been matched on in a case-control study: sex

Signature 1

Edit History Delete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Rimsha on 2022/04/6

Curated date: 2022/04/06

Curator: Rimsha

Revision editor(s): Rimsha, WikiWorks

Source: Figure 1a, 1b

Description: FISH analysis of main bacterial taxonomic groups in faeces of healthy and IBS patients

Abundance in Group 1: decreased abundance in constipated-IBS

NCBI	Quality Control	Links
Bifidobacterium
Eubacterium
Roseburia

Revision editor(s): Rimsha, WikiWorks

Signature 2

Edit History Delete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Rimsha on 2022/04/6

Curated date: 2022/04/06

Curator: Rimsha

Revision editor(s): Rimsha, WikiWorks

Source: Table 1

Description: Comparison of the population levels of microbial communities involved in carbohydrate metabolism in faecel samples from healthy and C-IBS individials

Abundance in Group 1: increased abundance in constipated-IBS

NCBI	Quality Control	Links
Enterobacteriaceae

Revision editor(s): Rimsha, WikiWorks

Signature 3

Edit History Delete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Rimsha on 2022/04/6

Curated date: 2022/04/06

Curator: Rimsha

Revision editor(s): Rimsha, Lwaldron, WikiWorks

Source: Table 1

Description: Comparison of the population levels of microbial communities involved in carbohydrate metabolism in faecel samples from healthy and C-IBS individials

Abundance in Group 1: decreased abundance in constipated-IBS

NCBI	Quality Control	Links
Lactobacillus
Bifidobacterium

Revision editor(s): Rimsha, Lwaldron, WikiWorks